AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionVerity & Verity, LLC
Latest Disclosed Ownership177,401 shares
Latest Disclosed Value $ 38,582,943
Verity & Verity, LLC reports 1.56% increase in ownership of 4AB / AbbVie Inc.

On April 15, 2026 - Verity & Verity, LLC filed a 13F-HR form disclosing ownership of 177,401 shares of AbbVie Inc. (BG:4AB) valued at $38,582,943 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 174,672 shares of AbbVie Inc.. This represents a change in shares of 1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ABBVIE COM 00287Y109 177,401 2,729 1.56 38,583 -3.33 2.8333
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 174,672 1,297 0.75 39,911 -0.58 3.0991
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 173,375 1,181 0.69 40,143 25.60 3.2128
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 172,194 -1,358 -0.78 31,963 -12.10 2.7474
2025-04-16 2025-03-31 13F ABBVIE COM 00287Y109 173,552 1,700 0.99 36,363 19.07 3.1934
2025-01-15 2024-12-31 13F ABBVIE COM 00287Y109 171,852 8,544 5.23 30,538 -5.31 2.7866
2024-11-07 2024-09-30 13F ABBVIE COM 00287Y109 163,308 1,131 0.70 32,250 15.94 3.1597
2024-11-07 2024-06-30 13F/A-2 ABBVIE COM 00287Y109 162,177 3,122 1.96 27,817 -3.96 3.0313
2024-09-16 2024-06-30 13F/A-1 ABBVIE COM 00287Y109 154,069 -4,986 26,426 3.0195
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 158,882 7,903 27,251 3.0283
2024-11-07 2024-03-31 13F/A-2 ABBVIE COM 00287Y109 159,055 -7,376 -4.43 28,964 12.30 3.2255
2024-09-16 2024-03-31 13F/A-1 ABBVIE COM 00287Y109 150,979 -15,452 27,493 3.2123
2024-11-07 2023-12-31 13F/A-1 ABBVIE COM 00287Y109 166,431 1,807 1.10 25,792 5.11 2.9560
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 163,136 -1,488 25,281 2.9547
2024-11-07 2023-09-30 13F/A-1 ABBVIE COM 00287Y109 164,624 2,821 1.74 24,539 12.56 3.0740
2023-10-19 2023-09-30 13F ABBVIE COM 00287Y109 160,953 -850 24,027 3.0589
2024-11-07 2023-06-30 13F/A-1 ABBVIE COM 00287Y109 161,803 16,667 11.48 21,800 -5.75 2.6742
2023-07-10 2023-06-30 13F ABBVIE COM 00287Y109 158,673 13,537 21,378 2.6739
2024-11-07 2023-03-31 13F/A-2 ABBVIE COM 00287Y109 145,136 5,178 3.70 23,130 2.26 2.9534
2024-05-02 2023-03-31 13F/A-1 ABBVIE COM 00287Y109 142,366 2,408 22,689 2.9556
2023-04-03 2023-03-31 13F ABBVIE COM 00287Y109 142,366 2,408 22,689 2.9556
2023-01-11 2022-12-31 13F ABBVIE COM 00287Y109 139,958 5,690 4.24 22,619 25.52 2.9523
2022-10-24 2022-09-30 13F ABBVIE COM 00287Y109 134,268 3,795 2.91 18,020 -9.82 2.9006
2022-08-18 2022-06-30 13F ABBVIE COM 00287Y109 130,473 -221 -0.17 19,983 -5.68 3.0597
2022-05-03 2022-03-31 13F ABBVIE COM 00287Y109 130,694 1,557 1.21 21,187 21.17 2.9357
2022-02-01 2021-12-31 13F ABBVIE COM 00287Y109 129,137 26,112 25.35 17,485 44.35 2.4984
2021-11-04 2021-09-30 13F ABBVIE COM 00287Y109 103,025 2,836 2.83 12,113 7.34 1.8127
2021-09-20 2021-06-30 13F ABBVIE COM 00287Y109 100,189 -197 -0.20 11,285 -0.63 1.7827
2021-06-21 2021-03-31 13F ABBVIE COM 00287Y109 100,386 8,733 9.53 11,356 13.65 1.8375
2021-01-12 2020-12-31 13F ABBVIE COM 00287Y109 91,653 9,322 11.32 9,992 38.03 1.8880
2020-10-06 2020-09-30 13F ABBVIE COM 00287Y109 82,331 2,309 2.89 7,239 -7.56 1.5923
2020-07-14 2020-06-30 13F ABBVIE COM 00287Y109 80,022 1,998 2.56 7,831 31.72 1.8666
2020-04-09 2020-03-31 13F ABBVIE COM 00287Y109 78,024 14,901 23.61 5,945 6.37 1.6753
2020-01-08 2019-12-31 13F ABBVIE COM 00287Y109 63,123 300 0.48 5,589 21.37 1.0845
2019-10-11 2019-09-30 13F ABBVIE COM 00287Y109 62,823 4,740 8.16 4,605 9.02 0.9746
2019-07-17 2019-06-30 13F ABBVIE COM 00287Y109 58,083 2,287 4.10 4,224 -6.07 0.9180
2019-04-29 2019-03-31 13F ABBVIE COM 00287Y109 55,796 4,626 9.04 4,497 -4.66 1.0320
2019-01-16 2018-12-31 13F ABBVIE COM 00287Y109 51,170 4,595 9.87 4,717 7.08 1.2619
2018-10-16 2018-09-30 13F ABBVIE COM 00287Y109 46,575 295 0.64 4,405 2.73 1.0619
2018-07-20 2018-06-30 13F/A-1 ABBVIE COM 00287Y109 46,280 620 1.36 4,288 -0.79 1.1129
2018-07-20 2018-06-30 13F ABBVIE COM 00287Y109 45,660 0 4,322
2018-04-25 2018-03-31 13F ABBVIE COM 00287Y109 45,660 -694 -1.50 4,322 -3.59 1.1628
2018-02-14 2017-12-31 13F/A-1 ABBVIE COM 00287Y109 46,354 1,152 2.55 4,483 11.60 1.2057
2018-02-09 2017-12-31 13F ABBVIE COM 00287Y109 45,202 0 4,017 1.1713
2017-10-31 2017-09-30 13F ABBVIE COM 00287Y109 45,202 1,185 2.69 4,017 25.85 1.1713
2017-08-11 2017-06-30 13F/A-1 ABBVIE COM 00287Y109 44,017 6,570 17.54 3,192 30.82 0.9795
2017-08-11 2017-06-30 13F ABBVIE COM 00287Y109 37,447 0 2,440 0.7588
2017-04-28 2017-03-31 13F ABBVIE COM 00287Y109 37,447 5,247 16.30 2,440 21.03 0.7588
2017-01-30 2016-12-31 13F ABBVIE COM 00287Y109 32,200 3,089 10.61 2,016 9.80 0.7006
2016-10-27 2016-09-30 13F ABBVIE COM 00287Y109 29,111 4,875 20.11 1,836 22.40 0.6742
2016-08-11 2016-06-30 13F Abbvie COM 00287Y109 24,236 4,918 25.46 1,500 35.99 0.5770
2016-04-28 2016-03-31 13F Abbvie COM 00287Y109 19,318 7,352 61.44 1,103 55.57 0.4678
2016-02-08 2015-12-31 13F Abbvie COM 00287Y109 11,966 11,966 0.00 709 0.3216
2015-11-04 2015-09-30 13F Abbvie COM 00287Y109 0 0 0 0.0000
2014-08-14 2014-06-30 13F ABBVIE COM 00287Y109 0 -61,461 -100.00 0 -100.00
2014-05-15 2014-03-31 13F ABBVIE COM 00287Y109 61,461 61,461 86.60 3,159 114.46 1.6749
2014-02-10 2013-12-31 13F Abbvie COM 00287Y109 0 -32,938 -100.00 0 -100.00
2013-11-06 2013-09-30 13F Abbvie COM 00287Y109 32,938 -7,046 -17.62 1,473 -10.89 0.8475
2013-08-14 2013-06-30 13F Abbvie COM 00287Y109 39,984 39,984 1,653 1.0113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.